Current Urology Reports

, 15:390

Multiparametric Magnetic Resonance Imaging in the Management and Diagnosis of Prostate Cancer: Current Applications and Strategies

  • Daniel J. Lee
  • Hashim U. Ahmed
  • Caroline M. Moore
  • Mark Emberton
  • Behfar Ehdaie
Prostate Cancer (D Parekh, Section Editor)

DOI: 10.1007/s11934-013-0390-1

Cite this article as:
Lee, D.J., Ahmed, H.U., Moore, C.M. et al. Curr Urol Rep (2014) 15: 390. doi:10.1007/s11934-013-0390-1
Part of the following topical collections:
  1. Topical Collection on Prostate Cancer

Abstract

Magnetic resonance imaging (MRI) has become increasingly used worldwide in the diagnosis and management of prostate cancer. With advances in multiparametric MRI (mpMRI) technology, such as the use of dynamic contrast-enhanced and diffusion-weighted imaging sequences, observational studies have evaluated the utility for mpMRI in the continuum of prostate cancer management, from improving the detection of clinically significant prostate cancer, to planning radical prostatectomy and radiation therapy and the early detection of local recurrence. Furthermore, the potential for advanced imaging to reduce the burden of routine serial prostate needle biopsies for men on active surveillance is a promising area of research. MRI technology continues to evolve, and the potential applications in the management of prostate cancer care will require well-designed multi-institutional prospective clinical trials and rigorous efforts to standardize reporting and improve dissemination of expertise across institutions.

Keywords

Prostate cancerMultiparametric magnetic resonance imagingActive surveillanceProstate-specific antigen (PSA)ManagementDiagnosis

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Daniel J. Lee
    • 1
  • Hashim U. Ahmed
    • 2
    • 3
  • Caroline M. Moore
    • 2
    • 3
  • Mark Emberton
    • 2
    • 3
  • Behfar Ehdaie
    • 4
    • 5
  1. 1.Department of Urology, Weill Cornell Medical CollegeNew York-Presbyterian HospitalNew YorkUSA
  2. 2.Department of UrologyUniversity College London Hospitals NHS Foundation TrustLondonUK
  3. 3.Division of Surgery and Interventional SciencesUniversity College LondonLondonUK
  4. 4.Department of Surgery, Division of UrologyMemorial Sloan-Kettering Cancer CenterNew YorkUSA
  5. 5.Department of Biostatistics and Epidemiology, Health Outcomes GroupMemorial-Sloan Kettering Cancer CenterNew YorkUSA